7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Human T-lymphotropic virus type 1 (HTLV-1) is the etiological agent of a slowly progressive neurodegenerative disease, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). This disease develops upon infiltration of HTLV-1-infected lymphocytes into the central nervous system, mostly the thoracic spinal cord. The central nervous system is normally protected by a physiological structure called the blood-brain barrier (BBB), which consists primarily of a continuous endothelium with tight junctions. In this study, we investigated the role of activated leukocyte cell adhesion molecule (ALCAM/CD166), a member of the immunoglobulin superfamily, in the crossing of the BBB by HTLV-1-infected lymphocytes. We demonstrated that ALCAM is overexpressed on the surface of HTLV-1-infected lymphocytes, both in chronically infected cell lines and in primary infected CD4 + T lymphocytes. ALCAM overexpression results from the activation of the canonical NF-κB pathway by the viral transactivator Tax. In contrast, staining of spinal cord sections of HAM/TSP patients showed that ALCAM expression is not altered on the BBB endothelium in the context of HTLV-1 infection. ALCAM blockade or downregulation of ALCAM levels significantly reduced the migration of HTLV-1-infected lymphocytes across a monolayer of human BBB endothelial cells. This study suggests a potential role for ALCAM in HAM/TSP pathogenesis.

          IMPORTANCE Human T-lymphotropic virus type 1 (HTLV-1) is the etiological agent of a slowly progressive neurodegenerative disease, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). This disease is the consequence of the infiltration of HTLV-1-infected lymphocytes into the central nervous system (CNS), mostly the thoracic spinal cord. The CNS is normally protected by a physiological structure called the blood-brain barrier (BBB), which consists primarily of a continuous endothelium with tight junctions. The mechanism of migration of lymphocytes into the CNS is unclear. Here, we show that the viral transactivator Tax increases activated leukocyte cell adhesion molecule (ALCAM/CD166) expression. This molecule facilitates the migration of lymphocytes across the BBB endothelium. Targeting this molecule could be of interest in preventing or reducing the development of HAM/TSP.

          Related collections

          Author and article information

          Contributors
          Role: Editor
          Journal
          J Virol
          J. Virol
          jvi
          jvi
          JVI
          Journal of Virology
          American Society for Microbiology (1752 N St., N.W., Washington, DC )
          0022-538X
          1098-5514
          1 June 2016
          27 July 2016
          15 August 2016
          : 90
          : 16
          : 7303-7312
          Affiliations
          [a ]Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, Institut Pasteur, Paris, France
          [b ]Centre National de la Recherche Scientifique (CNRS) UMR 3569, Paris, France
          [c ]Cellule Pasteur, Université Paris Diderot, Sorbonne Paris Cité, Paris, France
          [d ]Master Biosciences, Ecole Normale Supérieure (ENS) de Lyon, Lyon, France
          [e ]Equipe Oncogenèse Rétrovirale, ENS de Lyon, and Equipe labélisée Ligue Nationale Contre le Cancer, Centre International de Recherche en Infectiologie, INSERM U1111, CNRS UMR 5308, Lyon, France
          [f ]Département de Neuropathologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France
          [g ]Departamento de Ciencias Neurológicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile
          [h ]Institut Cochin, INSERM U1016, CNRS UMR 8104, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
          [i ]Service de Neurologie, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
          University of Illinois at Chicago College of Medicine
          Author notes
          Address correspondence to Philippe V. Afonso, pafonso@ 123456pasteur.fr .

          C.C. and F.P. contributed equally to this article.

          Citation Curis C, Percher F, Jeannin P, Montange T, Chevalier SA, Seilhean D, Cartier L, Couraud P-O, Gout O, Gessain A, Ceccaldi P-E, Afonso PV. 2016. Human T-lymphotropic virus type 1-induced overexpression of activated leukocyte cell adhesion molecule (ALCAM) facilitates trafficking of infected lymphocytes through the blood-brain barrier. J Virol 90:7303–7312. doi: 10.1128/JVI.00539-16.

          Article
          PMC4984663 PMC4984663 4984663 00539-16
          10.1128/JVI.00539-16
          4984663
          27252538
          8efa5009-ff97-4b2f-851c-94dfc50ccaf0
          Copyright © 2016, American Society for Microbiology. All Rights Reserved.
          History
          : 22 March 2016
          : 25 May 2016
          Page count
          Figures: 5, Tables: 1, Equations: 0, References: 47, Pages: 10, Words: 7721
          Funding
          Funded by: Ville de Paris
          Award ID: Emergence
          Award Recipient : Philippe V Afonso
          Funded by: Region Ile de France
          Award ID: DIM MALINF
          Award Recipient : Florent Percher
          Funded by: Ministère de l'Education Nationale (Ministry of Education, France) http://dx.doi.org/10.13039/501100003023
          Award Recipient : Celine Curis
          Categories
          Virus-Cell Interactions

          Comments

          Comment on this article